ApoA-IMilano/Phospholipid Complex. Clinical Implications of Dose-Response Studies in Rabbit Atherosclerosis With Intravascular Ultrasound and Magnetic Resonance Imaging**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 51, Issue 11, 2008, Pages 1110-1111

  Zhao, Xue Qiao ^a   Brown, B Greg ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CELL ADHESION MOLECULE; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ETC 216; GELATINASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOLIPID DERIVATIVE; PLACEBO; RECOMBINANT PROTEIN; SIMVASTATIN; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE CORONARY SYNDROME; AORTA INJURY; ATHEROMA; ATHEROSCLEROSIS; CELL DENSITY; CELL STRUCTURE; CHOLESTEROL INTAKE; COST BENEFIT ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG HALF LIFE; DRUG INHIBITION; ECHOGRAPHY; EDITORIAL; GENE EXPRESSION; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; MARKER GENE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; TREATMENT OUTCOME;

ANIMALS; ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEIN A-I; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID STENOSIS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MAGNETIC RESONANCE IMAGING; MALE; PHOSPHATIDYLCHOLINES; RABBITS; TREATMENT OUTCOME; ULTRASONOGRAPHY; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 40649120729     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.12.012     Document Type: Editorial

References (26)

1. Milano/1-palmitoyl-2-oleoyl phosphatidylcholine complex) administrations on rabbit lipid-rich soft plaques: in vivo assessment by intravascular ultrasound and magnetic resonance imaging. J Am Coll Cardiol 51 (2008) 1098-1103
2. Chiesa G., Di Mario C., Colombo N., et al. Development of a lipid-rich, soft plaque in rabbits, monitored by histology and intravascular ultrasound. Atherosclerosis 156 (2001) 277-287
3. Chiesa G., Monteggia E., Marchesi M., et al. Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks. Circ Res 90 (2002) 974-980
4. Shah PK, Yano J, Reyes O, et al. High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization. Circulation 200126;103:3047-50.
5. Shinnar M., Fallon J.T., Wehrli S., et al. The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. ATVB 19 (1999) 2756-2761
6. Cai J.M., Hatsukami T.S., Ferguson M.S., Small R., Polissar N.L., and Yuan C. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation 106 (2002) 1368-1373
7. Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis. J Am Coll Cardiol 51 (2008) 1104-1109
8. Corti R., Osende J.I., Fallon J.T., et al. The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging. J Am Coll Cardiol 43 (2004) 464-473
9. Nissen S.E., Tsunoda T., Tuzcu E.M., et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290 (2003) 2292-2300
10. Chiesa G., Monteggia E., Marchesi M., et al. Recombinant apolipoprotein A-I (Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks. Circ Res 90 (2002) 974-980
11. Kragel A.H., Reddy S.G., Wittes J.T., et al. Morphometric analysis of the composition of coronary arterial plaques in isolated unstable angina pectoris with pain at rest. Am J Cardiol 66 (1990) 562-567
12. Moreno P.R., Falk E., Palacios I.F., et al. Macrophage infiltration in acute coronary syndromes: Implications for plaque rupture. Circulation 90 (1994) 775-778
13. Davies M.J., Richardson P.D., Woolf N., et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophages, and smooth muscle cell content. Br Heart J 69 (1993) 377-381
14. Zhao X.Q., Chun Y., Hatsukami T.S., et al. Effects of intensive lipid-lowering therapy on carotid atherosclerotic plaque composition in vivo by MRI: a case-control study. ATVB 21 (2001) 1623-1629
15. Brown B.G., Brockenbrough A., Zhao X.-Q., et al. Very intensive lipid therapy with lovastatin, niacin, and colestipol for prevention of death and myocardial infarction: a 10-year Familial Atherosclerosis Treatment Study (FATS) follow-up. Circulation 98 Suppl (1998) I635
16. Brown B.G., Albers J.J., Fisher L.D., et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 323 (1990) 1289-1298
17. Brown B.G., Zhao X.Q., Chait A., et al. Simvastatin and niacin, antioxidant vitamins, or the combination for prevention of coronary disease. N Engl J Med 345 (2001) 1583-1592
18. Whitney E.J., Krasuski R.A., Personius B.E., et al. A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events. Ann Intern Med 142 (2005) 95-104
19. Anantharamaiah G.M., Mishra V.K., Garber D.W., et al. Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides. J Lipid Res 48 (2007) 1915-1923
20. Nicholls S.J., Dusting G.J., Cutri B., et al. Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation 111 (2005) 1543-1550
21. Baker P.W., Rye K.A., Gamble J.R., et al. Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression. J Lipid Res 41 (2000) 1261-1267
22. Weisgraber K.H., Rall Jr. S.C., Bersot T.P., et al. Apolipoprotein A-IMilano: detection of normal AI in affected subjects and evidence for a cysteine fpr arginine substitution in the variant A-I. J Biol Chem 258 (1983) 2508-2513
23. Milano mutant. Circulation 116 (2007) 2165-2172
24. Milano mutant: The Lomone sul Garda Study. Circulation 103 (2001) 1949-1954
25. Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al., Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285 (2001) 1711-1718
26. Cannon C.P., Braunwald E., McCabe C.H., et al. Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350 (2004) 15